Specialists and families have been taken by surprise that Southern Cross Health Insurance won't fund treatment.

Attention-deficit/hyperactivity disorder (ADHD) is a common but complex neurodevelopmental condition characterized by symptoms of inattention, hyperactivity, and ...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announce that ...

Medication and behavioral treatments are both widely used to treat ADHD. While medication is often the first-line treatment, patients who receive behavioral treatments—typically therapy, parent ...

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that causes hyperactivity and impulsivity in children and adults. If left untreated ...

Conducted in collaboration with UK-based virtual ADHD care provider ADHD360, the study addresses a longstanding challenge in ADHD assessment, linking objective performance data with outcomes that ...

Long-term methylphenidate use in childhood links to higher adult BMI and slightly shorter height, underscoring the need for ...

A new app hopes to provide a “lifeline” to the 2.5 million people in the UK with ADHD. Cog ADHD combines access to specialists with in-app treatment tools. The system is the brainchild of Dom Longford ...

NHS England pays for private assessments under ‘right to choose’, but can reject diagnoses and is struggling to cope with demand ...

Boys who stopped ADHD treatment at higher risk for negative consequences. Oct. 16, 2012 — -- Young boys who discontinue treatment for attention deficit hyperactivity disorder (ADHD) are featured ...

One mum has told how she was diagnosed herself before learning to manage the 'meltdowns, tears and explosive behaviour' in ...